≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Atypical mycobacterium lung infection

DOID EFO Endpoint Browser PheWeb

MYCOBLUNGATYPICA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — A31.0
  • Hospital discharge: ICD-9 — 310
  • Cause of death: ICD-10 — A31.0
  • Cause of death: ICD-9 — 310

2 out of 7 registries used, show all original rules.

407

4. Check minimum number of events

None

407

5. Include endpoints

None

407

6. Filter based on genotype QC (FinnGen only)

407

Control definitions (FinnGen only)

Control exclude
ASTHMA_PNEUMONIA

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
A31
Name in latin
Infectio pulmonalis mycobacterialis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3018 1576 1387
Only index persons 2203 1277 926
Unadjusted period prevalence (%)
Whole population 0.04 0.05 0.04
Only index persons 0.04 0.05 0.04
Median age at first event (years)
Whole population 68.38 71.46 64.83
Only index persons 67.81 70.61 63.93

-FinnGen-

Key figures

All Female Male
Number of individuals 407 225 182
Unadjusted period prevalence (%) 0.08 0.08 0.08
Median age at first event (years) 67.20 65.95 68.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
347
Matched controls
3468
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
+∞
323.0
328
*
J47
ICD-10 Finland
Bronchiectasis
63.8
101.2
116
27
UGC12
NOMESCO Finland
Flexible bronchoscopy
20.8
98.3
157
132
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
16.9
93.5
165
176
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
26.7
90.9
130
76
R03BB04
ATC
tiotropium bromide; inhalant
14.6
79.6
148
168
R03AK06
ATC
salmeterol and fluticasone; inhalant
11.0
68.5
149
222
J18.9
ICD-10 Finland
Pneumonia, unspecified
8.0
67.6
210
560
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
9.0
65.0
165
317
J01MA14
ATC
moxifloxacin; systemic
11.3
54.8
112
140
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
25.2
50.0
71
35
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
14.3
45.4
80
71
J45.9
ICD-10 Finland
Asthma, unspecified
6.9
45.3
133
288
TGC00
NOMESCO Finland
Bronchial lavation
24.2
44.7
64
32
J01MA12
ATC
levofloxacin; systemic
5.7
41.6
149
407
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
7.4
39.6
105
192
R03AC12
ATC
salmeterol; inhalant
15.7
39.4
66
51
R03DA04
ATC
theophylline; systemic, rectal
11.1
39.2
78
88
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.6
38.6
237
1111
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
8.0
37.8
93
151
J45.0
ICD-10 Finland
Predominantly allergic asthma
10.1
36.2
76
94
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
12.1
35.5
67
67
R03AC02
ATC
salbutamol; inhalant
4.4
35.4
250
1287
J45.1
ICD-10 Finland
Nonallergic asthma
11.1
34.9
69
76
A31.9
ICD-10 Finland
Mycobacterial infection, unspecified
+∞
33.9
32
*
GD1AD
NOMESCO Finland
Thorax CT examination
12.6
33.6
62
59
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.8
30.0
226
1151
H02AB06
ATC
prednisolone; systemic
3.8
29.9
227
1162
R04.2
ICD-10 Finland
Haemoptysis
12.8
29.3
53
48
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
16.8
29.2
47
32
R03DC03
ATC
montelukast; oral
5.3
28.5
98
239
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
33.3
27.8
36
12
R03BA05
ATC
fluticasone; inhalant
4.4
25.5
108
324
R03AC03
ATC
terbutaline; inhalant
4.8
25.1
95
254
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.1
24.2
113
369
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
256.9
24.0
24
*
J01FA06
ATC
roxithromycin; oral
3.2
23.0
189
947
H02AB04
ATC
methylprednisolone; systemic
4.4
22.2
90
255
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
7.3
22.1
55
87
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
6.4
20.8
57
103
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.5
19.0
42
55
H02AB07
ATC
prednisone; oral
3.8
18.6
88
283
J96.1
ICD-10 Finland
Chronic respiratory failure
15.5
18.5
30
21
R03BA01
ATC
beclometasone; inhalant
3.9
18.4
85
267
R03BA02
ATC
budesonide; inhalant
3.6
18.2
95
328
3101A
ICD-9 Finland
Specific nonpsychotic mental disorders following organic brain damage, Organic personality syndrome
+∞
17.9
17
*
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
189.2
17.7
18
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
6.7
17.4
45
75
R03BB01
ATC
ipratropium bromide; inhalant
6.5
17.2
46
80
R03AK08
ATC
formoterol and beclometasone; inhalant
9.4
16.9
35
41
R03AC13
ATC
formoterol; inhalant
6.5
16.2
43
74
J46
ICD-10 Finland
Status asthmaticus
12.6
15.9
28
24
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
27.8
15.8
21
8
J01AA02
ATC
doxycycline; systemic
3.1
15.7
293
2204
R81
ICPC
Pneumonia
9.6
15.3
31
35
XG410
NOMESCO Finland
Flow-volume spirometry
6.9
14.7
37
59
J45.8
ICD-10 Finland
Mixed asthma
14.4
13.9
23
17
TDM10
NOMESCO Finland
Puncture of maxillary antrum
8.3
13.7
30
39
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.4
13.4
29
37
J45
ICD-10 Finland
Asthma
4.2
13.3
52
139
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
12.6
81
319
SPAT1017
SPAT
Examination of colour vision
+∞
12.6
12
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.9
12.1
40
90
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
11.8
158
930
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
31.2
11.7
15
5
J01FA09
ATC
clarithromycin; systemic
2.4
11.7
120
616
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
5.8
11.7
33
62
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
7.9
11.7
26
35
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
123.9
11.5
12
*
A02BC02
ATC
pantoprazole; systemic
2.3
11.4
245
1779
R02
ICPC
Shortness of breath/dyspnoea
3.1
11.2
66
244
R03DC01
ATC
zafirlukast; oral
12.5
11.0
19
16
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
22.3
10.8
15
7
R05
ICD-10 Finland
Cough
2.6
10.8
88
399
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.4
10.7
115
603
A31.89
ICD-10 Finland
Other mycobacterial infections
+∞
10.5
10
*
348
Kela drug reimbursment
Roflumilast
+∞
10.5
10
*
A31.80
ICD-10 Finland
Oral infection caused by Mycobacterium intracellulare
+∞
10.5
10
*
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
+∞
10.5
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
10.3
49
155
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.0
10.2
41
112
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
6.4
10.2
26
43
R03BA08
ATC
ciclesonide; inhalant
3.8
10.1
43
124
R06.0
ICD-10 Finland
Dyspnoea
2.3
10.0
112
592
R95
ICPC
Chron obstructive pulmonary disease
8.5
10.0
21
26
R50.9
ICD-10 Finland
Fever, unspecified
2.9
10.0
64
250
R03BB02
ATC
oxitropium bromide; inhalant
20.8
9.9
14
7
R01AD09
ATC
mometasone; nasal
2.1
9.8
157
977
R03AK07
ATC
formoterol and budesonide; inhalant
2.6
9.8
75
327
J01CA04
ATC
amoxicillin; systemic
2.3
9.7
271
2126
R03AK11
ATC
formoterol and fluticasone; inhalant
7.9
9.6
21
28
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.8
9.4
31
70
R03DX07
ATC
roflumilast; oral
+∞
9.4
9
*
J01GB01
ATC
tobramycin; inhalant, parenteral
+∞
9.4
9
*
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
9.9
9.4
18
19
J01FA10
ATC
azithromycin; systemic
2.0
9.2
193
1327
J02AC01
ATC
fluconazole; systemic
2.1
9.2
137
820
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
37.7
9.1
11
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
9.0
121
693
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
8.3
9.0
19
24
A01AB04
ATC
amphotericin B; local oral
4.2
8.9
33
84
R01AD08
ATC
fluticasone; nasal
2.2
8.8
105
571
J02AC03
ATC
voriconazole; systemic
51.3
8.7
10
*
A03
ICPC
Fever
2.7
8.6
60
246
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.8
8.4
35
100
J20
ICD-10 Finland
Acute bronchitis
3.1
8.3
47
169
R05
ICPC
Cough
2.2
8.3
96
513
J01FA15
ATC
telithromycin; oral
3.1
8.1
45
159
XQ800
NOMESCO Finland
Prick test
3.8
7.9
33
94
49300
ICD-8 Finland
Asthma, bronchiale
7.2
7.9
18
26
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
11.2
7.9
14
13
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
6.6
7.8
19
30
R24
ICPC
Haemoptysis
18.9
7.6
11
6
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
18.9
7.6
11
6
1240
FHL
Bronchoscopy
10.4
7.6
14
14
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
7.4
128
796
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
7.4
77
389
R05DA20
ATC
opium alkaloids and derivatives - combinations
2.1
7.3
97
546
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
+∞
7.3
7
*
0310A
ICD-9 Finland
Diseases due to other mycobacteria, Pulmonary
+∞
7.3
7
*
M05BA04
ATC
alendronic acid; oral
2.7
7.3
52
215
XG474
NOMESCO Finland
Exhalation nntrogen oxide
7.6
7.3
16
22
A07AA02
ATC
nystatin; oral
3.3
7.2
35
113
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.8
7.2
19
34
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.4
7.1
33
103
WW200
NOMESCO Finland
Immunization
5.1
6.8
20
41
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.1
6.7
14
18
SPAT1255
SPAT
Intravenous administration of medicine
3.2
6.6
33
110
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
71.1
6.4
7
*
A15.2
ICD-10 Finland
Tuberculosis of lung, confirmed histologically
+∞
6.3
6
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
+∞
6.3
6
*
4226
FHL
Posterior radical surgery and possible etmoidectomy
27.2
6.3
8
*
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
7.9
6.2
13
17
L04AA06
ATC
mycophenolic acid; systemic
7.9
6.2
13
17
J01MA02
ATC
ciprofloxacin; systemic
1.8
6.2
144
983
A01AB09
ATC
miconazole; local oral
2.7
6.1
42
171
WX892
NOMESCO Finland
Monitored bed care
2.9
6.0
35
129

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
165
101
26.79
208.36
10.1
3.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
111
33
45.88
180.44
6.5
2.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
93
29
41.27
148.25
13.4
2.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
82
46
22.07
104.58
15.6
2.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
61
17
42.03
99.22
2.0
1.3
u/ml
1.8
0.1
—
44
8
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
73
47
18.71
86.74
1.8
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
78
59
16.12
85.10
1.8
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
81
72
13.80
80.23
3.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
59
34
20.13
73.62
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
158
375
6.25
67.88
3.8
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
62
47
15.38
67.10
1.6
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
64
52
14.42
66.54
1.6
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
98
161
7.70
60.21
2.1
1.2
u/ml
181.7
280.5
0.29
92
147
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
49
31
17.83
58.15
2.1
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
35
11
34.72
54.34
1.6
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
60
9
77.82
53.86
16.3
5.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
42
26
17.90
50.22
2.6
2.1
e9/l
1.4
1.4
0.00
14
11
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
37
21
19.28
46.01
2.5
1.9
e6/l
2827.2
484.6
0.61
24
11
(3005719) IgG [Mass/volume] in Serum or Plasma
102
230
5.58
44.73
3.1
2.8
g/l
10.6
10.2
0.36
97
207
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
62
85
8.43
44.07
2.4
1.6
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
34
18
20.52
43.57
1.2
1.3
g/l
0.4
0.4
0.05
21
12
(4062490)
34
20
18.46
41.49
1.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
59
82
8.25
41.39
2.5
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
38
31
13.42
38.93
1.2
1.4
g/l
0.8
0.6
0.42
24
26
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
50
62
9.05
38.41
2.7
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
154
552
3.88
36.45
3.0
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
227
1051
3.62
36.22
17.4
5.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
30
18
17.91
36.17
1.7
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
85
196
5.22
35.88
1.8
1.9
g/l
1.3
1.4
0.10
78
174
(3042936) Bacteria identified in Isolate by Culture
138
464
3.99
35.75
2.2
2.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
285
1549
3.80
34.86
16.8
5.2
e9/l
0.0
0.0
1.57
272
1325
(3001604) Monocytes [#/volume] in Blood
284
1541
3.79
34.80
16.8
5.1
e9/l
0.7
0.6
0.91
271
1316
(3013115) Eosinophils [#/volume] in Blood
287
1597
3.70
33.16
17.9
5.4
e9/l
0.2
0.2
0.12
277
1396
(3019198) Lymphocytes [#/volume] in Blood
285
1583
3.67
32.93
17.1
5.2
e9/l
1.8
1.9
0.43
273
1395
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
36
5
78.57
32.43
1.5
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
24
11
23.12
32.42
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
109
372
3.64
26.81
1.4
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
21
13.16
26.59
1.9
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
34
41
8.96
26.50
2.7
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
24
17
14.94
26.42
2.0
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
24
18
14.11
25.59
2.0
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
23
16
15.18
25.54
3.3
2.6
%
15.8
10.6
—
10
10
(3030905) Polymorphonuclear cells [#/volume] in Blood
38
56
7.38
25.06
5.5
3.0
e9/l
5.1
4.3
0.94
38
56
(3013650) Neutrophils [#/volume] in Blood by Automated count
291
1809
3.14
24.49
19.5
8.8
e9/l
4.9
4.1
4.35
279
1576
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
60
6.88
23.52
5.6
3.6
%
62.6
57.8
1.26
38
60
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
15
14.71
22.94
2.2
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
15
14.71
22.94
2.2
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
15
14.71
22.94
2.2
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
15
14.71
22.94
2.2
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
127
522
3.08
22.67
7.7
3.3
mmol/l
0.8
0.8
0.33
122
485
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
20
15
13.97
21.23
3.8
2.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
76
242
3.63
20.38
1.7
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
29
9.12
19.98
2.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
29
9.12
19.98
2.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
29
9.12
19.98
2.2
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
178
929
2.63
19.70
7.7
4.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
11
16.08
19.46
2.4
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
11
16.08
19.46
2.4
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
99
383
3.09
19.33
2.7
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
52
6.59
19.22
2.7
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
12
14.74
18.58
2.5
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
268
1754
2.55
17.64
13.4
6.1
umol/l
9.0
11.2
7.85
259
1651
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
96
384
2.96
17.54
2.8
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
61
5.80
17.43
1.8
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
61
5.80
17.43
1.8
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
70
235
3.39
17.17
7.3
4.2
%
2.2
0.5
0.47
23
65
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
33
62
5.70
17.13
14.4
7.0
iu/ml
152.8
154.1
—
6
10
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
136
4.05
16.69
3.5
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
64
207
3.48
16.62
5.7
3.4
mmol/l
1.8
1.9
0.10
51
160
(3007164) IgA [Mass/volume] in Serum or Plasma
123
576
2.63
16.51
1.7
1.5
g/l
2.5
2.5
0.00
88
314
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
37
7.13
16.32
2.7
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
25
38
6.94
15.93
2.7
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
29
7.96
15.84
2.1
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
65
219
3.34
15.80
6.5
3.4
ph
7.4
7.4
1.94
12
27
(3012501) Base excess in Blood by calculation
36
79
4.90
15.73
7.5
3.0
mmol/l
3.2
2.8
0.32
27
43
(4010399)
66
226
3.29
15.63
1.8
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
38
91
4.50
14.94
2.2
1.5
iu/ml
0.2
0.1
—
5
18
(3007853) Bacteria identified in Skin by Aerobe culture
88
364
2.81
14.93
1.8
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
255
1723
2.29
14.27
9.9
6.3
mmol/l
1.2
1.2
0.02
208
1431
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
45
127
3.86
14.23
2.8
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
70
263
3.01
14.11
7.8
4.1
%
1.6
0.9
0.45
27
89
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
91
4.37
14.06
1.9
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
67
247
3.05
13.96
8.0
4.2
%
0.0
0.1
0.83
25
81
(3025159) Blasts/100 leukocytes in Blood
65
236
3.09
13.90
7.6
4.3
%
0.0
0.1
0.66
23
70
(1616796) Gas panel - Central venous blood
32
71
4.81
13.78
6.6
2.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
89
393
2.62
13.18
1.4
1.3
titre
603.1
473.8
0.19
26
90
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
235
1575
2.16
12.90
8.9
5.6
mmol/l
1.2
1.2
0.12
225
1391
(3000492) Spirometry study
64
246
2.90
12.32
2.9
1.5
—
—
—
0
0
(3010421) pH of Blood
36
96
4.02
12.29
7.5
3.0
ph
7.4
7.4
1.09
36
77
(3021901) Oxygen saturation in Capillary blood
28
67
4.41
10.99
3.3
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
120
655
2.18
10.80
10.9
4.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
310
2399
2.23
10.75
11.6
4.1
mm/h
19.3
13.3
6.37
301
2173
(3022313) Gas panel - Capillary blood
47
165
3.09
10.58
7.1
3.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
93
3.77
10.43
3.4
2.2
u/ml
0.4
0.4
0.31
20
51
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
70
4.22
10.40
1.4
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
12
14
8.80
9.39
1.4
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
62
4.23
9.38
1.4
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
163
1046
1.93
9.13
6.7
3.7
ph
7.4
7.4
0.91
48
208
(3004588) Protein electrophoresis panel - Serum or Plasma
59
253
2.56
9.12
1.6
2.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
14
9
16.05
9.09
1.4
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
12
5
24.66
8.95
2.5
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
25
65
4.03
8.82
2.6
2.3
%
15.6
15.8
0.04
13
33
(44790048)
19
41
4.81
8.43
3.0
1.4
—
—
—
0
0
(44790049)
19
41
4.81
8.43
3.0
1.4
—
—
—
0
0
(44806118)
19
41
4.81
8.43
3.0
1.4
—
—
—
0
0
(44790047)
19
41
4.81
8.43
3.0
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
208
1472
1.84
8.39
5.8
4.5
g/l
32.8
35.3
5.91
192
1369
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
30
5.51
8.27
1.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
63
292
2.37
8.22
1.6
2.4
g/l
64.6
65.8
0.47
53
262
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
203
2.61
8.11
2.3
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
61
3.94
7.91
3.3
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
50
218
2.47
7.44
3.2
6.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
23
64
3.75
7.41
1.9
2.2
g/l
122.6
129.6
0.51
15
49
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
64
3.75
7.41
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
16
34
4.86
7.22
8.5
4.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
132
848
1.82
7.01
2.5
2.1
mg/l
3.2
3.2
0.04
119
710
(3032080) INR in Blood by Coagulation assay
198
1433
1.74
6.98
9.6
9.9
inr
1.2
1.3
0.89
65
408
(3001122) Ferritin [Mass/volume] in Serum or Plasma
181
1283
1.74
6.83
3.0
2.7
ug/l
118.6
130.7
0.46
170
1148
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
6
17.04
6.77
3.0
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
88
505
1.95
6.59
1.2
1.3
iu/ml
90.4
40.0
0.56
29
154
(40758558) Short blood count panel - Blood
124
797
1.80
6.50
13.8
6.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
146
985
1.75
6.48
4.6
3.1
u/l
33.0
32.5
0.04
141
938
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
307
2545
1.84
6.48
18.3
7.3
u/l
81.1
80.1
0.16
302
2362
(3022806) Fractional oxyhemoglobin in Capillary blood
17
42
4.18
6.42
2.1
1.9
%
89.4
90.0
0.16
17
42
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
159
1107
1.72
6.27
3.4
3.1
ng/l
1362.1
1434.2
0.11
142
937
(3013826) Glucose [Moles/volume] in Serum or Plasma
245
1925
1.69
6.05
7.8
4.8
mmol/l
6.5
6.8
1.13
237
1795
(3022948) Iron [Moles/volume] in Serum or Plasma
89
531
1.87
5.88
2.6
2.4
umol/l
12.0
12.5
0.31
83
482
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
212
1612
1.66
5.87
3.2
2.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
73
409
1.96
5.82
9.3
5.2
mmol/l
1.0
1.1
0.69
68
371
(3021589) Normoblasts [#/volume] in Blood
188
1389
1.66
5.81
24.6
9.9
e9/l
0.0
0.0
0.55
169
1145
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
29
113
2.69
5.43
1.7
2.3
g/l
0.7
0.4
0.19
24
95
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
54
281
2.06
5.28
3.7
3.0
ng/l
182.9
187.5
0.04
49
250
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
124
2.53
5.01
1.7
2.0
g/l
3.5
3.3
0.70
23
96
(3019225) pH of Specimen
63
355
1.92
4.92
5.7
3.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
64
364
1.90
4.86
5.3
7.7
mmol/l
2.9
1.2
2.47
54
287
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
104
685
1.70
4.84
2.5
1.6
mg/l
1.3
1.3
0.05
83
544
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
134
2.42
4.72
1.6
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
134
2.42
4.72
1.6
2.0
g/l
3.7
3.8
0.10
23
95
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
134
2.42
4.72
1.6
2.0
g/l
8.0
7.6
0.38
24
97
(3048689) Calprotectin [Mass/mass] in Stool
64
369
1.87
4.66
2.2
2.1
ug/g
155.8
132.4
0.27
42
285
(3052851) Hemolysis interference index of Serum or Plasma
24
92
2.71
4.65
3.6
3.3
—
—
—
0
0
(3013512) EKG study
147
1068
1.59
4.60
6.4
4.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
304
1.94
4.55
2.9
2.9
e9/l
72.7
70.5
0.12
38
242
(36304419) Bacteria [Presence] in Urine
127
896
1.61
4.47
5.5
3.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
75
462
1.76
4.40
2.8
2.4
%
18.7
21.9
1.64
66
393
(3004789) Transferrin [Mass/volume] in Serum or Plasma
77
478
1.75
4.40
2.8
2.4
g/l
2.3
2.3
0.23
71
440
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
126
2.40
4.38
1.7
2.0
g/l
9.6
10.3
0.41
23
105
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
61
3.04
4.34
3.6
2.7
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
6
11.84
4.29
1.1
1.0
%
97.9
95.3
—
7
6
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
6
11.84
4.29
1.1
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
27
115
2.44
4.26
1.3
3.2
—
2.8
—
0
11
(3033658) Prothrombin time (PT) actual/Normal
114
793
1.61
4.23
6.7
3.6
%
93.0
88.6
1.13
109
775
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
27
116
2.42
4.18
1.4
3.3
mg/l
32.9
28.3
0.39
20
84
(3034860) Kappa light chains.free [Mass/volume] in Serum
27
116
2.42
4.18
1.4
3.3
mg/l
232.6
122.4
0.24
19
84
(3037121) Protein [Mass/volume] in Urine
27
116
2.42
4.18
3.5
3.0
g/l
0.2
0.3
0.72
13
42
(40768804) Tissue Pathology biopsy report
166
1262
1.53
4.16
2.6
2.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
80
2.71
4.13
1.2
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
42
220
2.01
4.05
6.6
2.9
e9/l
4.8
3.7
1.27
32
163
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
279
3144
0.64
3.98
5.5
5.3
mmol/l
2.5
2.7
1.40
249
2829
(3030467) Casts [#/volume] in Urine by Automated count
130
948
1.55
3.89
5.7
3.1
e6/l
0.3
0.5
0.72
111
716
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
16
54
3.04
3.89
1.1
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
11
7.39
3.87
4.4
1.5
umol/l
24.4
30.6
—
8
11
(3017704) Immunofixation for Urine
9
15
6.11
3.83
1.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
34
3.61
3.79
1.3
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
55
2.99
3.78
1.1
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
173
1348
1.49
3.76
5.3
4.0
ng/l
74.6
68.4
0.04
135
1019
(3002582) Erythrocytes [#/volume] in Urine
139
1036
1.52
3.74
5.5
3.3
e6/l
13.9
107.1
0.88
120
806
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
16
5.73
3.67
2.4
2.7
u/ml
628.7
805.2
—
9
16
(3034426) Prothrombin time (PT)
7
9
7.89
3.57
1.6
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
17
63
2.77
3.53
1.6
1.3
mmol/l
50.2
58.4
0.38
12
53
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
94
651
1.58
3.49
1.3
1.3
u/ml
1.3
1.7
0.37
18
155
(3027945) Reticulocytes/100 erythrocytes in Blood
65
412
1.69
3.43
2.8
2.6
%
1.8
1.8
0.05
59
362
(3044927) Protein electrophoresis panel - Urine
12
37
3.31
3.37
1.3
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
154
1193
1.47
3.36
6.1
3.9
e6/l
33.2
99.0
2.96
124
862
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
472
1.64
3.35
1.3
1.3
u/ml
18.3
11.5
0.16
15
165
(3015377) Calcium [Moles/volume] in Serum or Plasma
151
1167
1.47
3.33
4.6
3.3
mmol/l
2.3
2.4
1.07
135
1003
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
43
3.09
3.28
1.8
1.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
7
8.68
3.27
1.5
1.0
mmol/l
-0.5
3.8
—
6
7
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
33
3.40
3.21
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
48
286
1.77
3.16
5.6
6.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
48
286
1.77
3.16
8.2
4.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
50
2.86
3.11
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
156
1227
1.44
3.09
5.6
3.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
23
107
2.22
3.03
1.2
1.2
—
1.1
—
0
9
(3002032) Base excess in Venous blood by calculation
54
337
1.69
3.02
8.3
3.3
mmol/l
3.2
2.1
1.11
48
256
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
361
1.67
3.02
5.8
3.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
139
1074
1.45
3.02
3.1
2.4
u/l
53.4
57.4
0.94
133
989
(3021960) Folate [Moles/volume] in Serum or Plasma
117
875
1.47
3.01
1.5
1.6
nmol/l
19.6
21.5
0.73
102
717
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
69
2.53
3.00
2.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
170
1368
1.42
2.94
2.7
2.2
nmol/l
84.2
77.8
2.30
151
1178
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
92
659
1.51
2.91
4.5
3.9
ng/l
442.3
259.8
0.47
74
546
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
9
6.75
2.87
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
9
6.75
2.87
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
277
3065
0.70
2.78
5.1
4.7
mmol/l
4.5
4.6
0.16
243
2772
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
72
2.42
2.76
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
37
3.03
2.71
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
10
6.07
2.70
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
24
3.81
2.68
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
86
2.27
2.68
1.3
3.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
13
49
2.71
2.65
1.2
1.2
u/ml
125.0
102.2
—
5
10
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
279
1.69
2.60
1.9
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
25
3.66
2.59
2.7
2.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
25
3.66
2.59
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
25
3.66
2.59
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
101
2.14
2.57
1.4
1.4
ug/g
247.8
275.1
—
9
53
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
44
2.78
2.57
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
276
3041
0.71
2.53
5.0
4.7
mmol/l
1.6
1.5
3.51
244
2732
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
102
2.12
2.52
1.5
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
39
2.87
2.49
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
16
4.43
2.48
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
16
4.43
2.48
1.3
1.4
—
—
—
0
0
(4306422)
10
34
2.99
2.43
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
280
3071
0.72
2.42
5.3
4.9
mmol/l
5.9
6.0
1.41
253
2734
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
271
2980
0.73
2.30
6.2
6.3
mmol/mol
40.4
40.5
0.04
251
2731
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
18
3.94
2.26
1.3
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
10
5.05
2.07
10.4
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
252
2242
1.33
2.02
7.3
4.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
26
3.12
2.02
1.4
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
70
2.19
2.01
19.3
2.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
45
2.48
1.94
1.5
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
27
3.00
1.94
1.1
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
27
3.00
1.94
1.1
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
16
3.79
1.94
1.5
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
16
3.79
1.94
1.5
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
17
85
2.04
1.93
5.4
11.4
mmol/l
1.2
1.2
0.00
17
74
(40768797) Stomach Pathology biopsy report
64
465
1.45
1.88
1.4
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
28
2.89
1.87
1.5
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
94
732
1.37
1.87
1.8
1.8
nmol/l
1330.7
1199.2
0.60
70
527
(3026493) Urate [Moles/volume] in Serum or Plasma
103
814
1.36
1.86
4.8
2.8
umol/l
3848.5
7674.1
0.47
97
681
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
40
2.54
1.85
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
23
3.08
1.80
1.6
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
29
2.79
1.80
3.1
2.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
47
2.38
1.79
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
47
2.38
1.79
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
47
2.38
1.79
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
47
2.38
1.79
1.5
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
10
41
2.48
1.76
1.4
1.1
u/ml
1.4
1.5
—
5
11
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
41
2.48
1.76
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
18
3.37
1.75
1.3
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
18
3.37
1.75
1.2
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
13
3.88
1.72
3.8
1.7
ug/l
83.0
72.8
—
5
13
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
48
2.33
1.72
1.5
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
75
571
1.38
1.71
4.3
2.8
e6/l
0.8
1.3
1.03
50
338
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
86
670
1.36
1.70
2.7
3.1
mmol/l
2.5
2.5
1.55
75
588
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
271
2937
0.77
1.69
4.4
4.2
mmol/l
1.2
1.3
2.77
235
2617
(3026008) Bacteria identified in Urine by Culture
137
1143
1.30
1.69
4.1
3.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
91
1.91
1.63
2.2
1.5
—
—
—
0
0
(4268621)
8
32
2.53
1.60
3.0
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
192
1.61
1.59
1.9
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
15
3.36
1.53
1.8
1.3
umol/l
12.0
15.7
—
5
15
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
15
3.36
1.53
1.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
51
371
1.43
1.51
3.1
2.9
umol/l
6.0
8.9
0.94
46
329
(3004451) EKG impression Narrative
6
21
2.88
1.51
2.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
155
1.65
1.50
8.9
11.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
99
803
1.31
1.49
3.4
2.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
37
2.46
1.49
2.8
2.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
38
2.40
1.46
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
43
305
1.46
1.46
2.2
2.5
u/l
32.2
32.4
0.02
37
251
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
262
2399
1.26
1.42
4.4
3.9
pmol/l
15.1
14.9
0.31
238
2116
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
29
2.44
1.40
3.1
2.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
29
2.44
1.40
1.6
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
199
1.55
1.39
1.7
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
41
2.22
1.38
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
167
1459
1.25
1.36
2.1
2.0
pmol/l
94.1
95.3
0.12
95
728
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
124
1051
1.26
1.31
2.8
2.1
u/l
122.1
199.3
2.35
119
973
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
43
2.12
1.31
1.0
1.0
—
—
—
0
0
(4035726)
42
304
1.43
1.30
1.5
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
18
2.80
1.29
1.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
139
1.62
1.26
1.2
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
36
2.25
1.25
1.1
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
62
483
1.33
1.24
33.5
23.8
inr
1.6
1.2
0.99
14
66
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
12
63
1.93
1.24
2.2
2.7
mg/l
28.8
27.8
—
5
22
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
93
1.75
1.23
2.9
2.8
ug/min
118.1
109.8
—
10
58
(3044640) Blood type and Crossmatch panel - Blood
123
1052
1.24
1.19
3.2
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
52
398
1.35
1.17
1.3
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
226
1.45
1.14
1.1
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
30
2.36
1.13
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
168
1.52
1.12
1.5
1.3
—
—
—
0
0
(4094501)
13
73
1.81
1.12
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
193
0.56
1.10
7.3
3.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
67
539
1.29
1.08
4.8
3.0
e6/l
2.5
2.9
0.16
43
309
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
137
1.56
1.08
2.0
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
788
0.78
1.06
3.9
4.5
%
19.3
21.7
0.69
29
407
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
42
317
1.36
1.05
2.0
2.6
ug/l
8.1
7.4
0.10
34
276
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
328
3126
1.25
1.02
40.6
15.2
mg/l
23.8
23.9
0.04
307
2502
(1761482) Bacteria [#/volume] in Urine by Culture
5
110
0.45
1.01
8.2
4.9
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
210
1924
1.19
0.97
7.1
3.1
u/l
48.2
51.4
0.23
198
1772
(3019150) Specific gravity of Urine by Refractometry
58
714
0.78
0.97
4.5
4.7
kg/l
1.0
1.0
0.50
17
99
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
77
1.71
0.96
1.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
5
101
0.49
0.90
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
30
2.01
0.87
1.3
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
331
3431
0.81
0.87
51.7
22.6
fl
91.6
91.4
0.29
331
3368
(3035941) MCH [Entitic mass]
331
3431
0.81
0.87
51.6
22.6
pg
30.1
30.4
2.26
331
3368
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
257
1.35
0.86
3.1
2.8
ml/min/173m2
74.7
59.1
1.36
17
105
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
46
1.75
0.83
1.6
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
50
403
1.27
0.82
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
173
1.41
0.81
2.9
2.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
9
151
0.59
0.80
1.4
3.2
u/ml
29.3
2027.5
—
9
131
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
75
1.62
0.75
1.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
24
2.10
0.74
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
101
1.50
0.71
1.7
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
41
1.72
0.70
1.6
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
313
3245
0.85
0.70
29.8
14.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
69
1.61
0.69
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
2.2
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
103
1.47
0.66
1.7
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
40
324
1.26
0.65
1.6
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
51
428
1.22
0.62
14.1
6.0
mmol/l
103.0
103.9
0.85
51
418
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
441
0.80
0.61
8.2
7.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
105
1.44
0.61
1.7
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
48
569
0.82
0.60
3.3
3.1
ug/l
1.0
0.8
0.19
35
388
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
88
779
1.17
0.60
1.7
1.7
pmol/l
460.0
9677866.5
0.50
70
620
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
85
956
0.86
0.58
3.2
3.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
23
0.00
0.58
0.0
1.2
—
22300.5
—
0
16
(3020682) Albumin/Creatinine [Ratio] in Urine
97
1079
0.87
0.57
5.7
3.9
mg/mmol
10.1
10.4
0.02
72
660
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
55
1.46
0.56
1.4
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
99
1.43
0.55
1.6
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
89
991
0.87
0.54
5.8
5.2
ug/l
3.1
3.1
0.02
74
878
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
39
1.55
0.53
1.3
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
83
740
1.15
0.52
4.3
4.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
40
1.51
0.52
5.7
4.0
u/ml
29.6
37.4
—
6
40
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
108
0.64
0.49
1.7
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
46
1.53
0.48
1.4
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
46
1.53
0.48
25.1
8.0
mmol/l
8.7
6.3
—
7
37
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
94
1.40
0.46
3.3
1.7
—
—
—
0
0
(3020891) Body temperature
18
138
1.32
0.46
4.6
4.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
50
1.41
0.45
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
50
1.41
0.45
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
50
1.41
0.45
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
31
1.62
0.43
2.0
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
96
877
1.12
0.43
6.0
4.6
estimate
0.0
0.0
0.00
49
299
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
116
1252
0.90
0.43
6.1
4.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
390
0.83
0.42
1.4
1.4
—
—
—
0
0
(4024509)
5
32
1.57
0.42
2.0
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
0.9
—
0
15
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
159.3
—
0
16
(44806420)
0
18
0.00
0.40
0.0
2.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
18
0.00
0.40
0.0
18.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
35
1.43
0.39
4.6
2.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
67
1.35
0.38
1.0
1.2
—
33.4
—
0
7
(3043409) Potassium [Moles/volume] in Arterial blood
8
112
0.71
0.37
2.9
3.5
mmol/l
3.7
4.0
—
8
102
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
152
1.26
0.37
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
81
1.37
0.36
1.3
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
76
0.65
0.36
1.2
1.5
pmol/l
118.2
238.8
—
5
76
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
91
839
1.11
0.35
1.7
1.6
mmol/l
1.3
1.3
0.40
76
683
(3012516) Albumin [Mass/volume] in Urine
94
1015
0.90
0.35
4.5
3.2
mg/l
915.5
259.4
0.53
73
631
(40768806) Pleura Pathology biopsy report
6
43
1.40
0.35
1.8
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
44
1.37
0.34
1.0
2.5
pg
31.2
33.1
—
6
44
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
74
1.36
0.32
1.1
1.1
—
13.1
—
0
8
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
107
0.74
0.29
1.6
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
195
1.19
0.29
2.5
2.6
—
7.0
—
0
5
(3009508) Creatinine [Moles/volume] in Urine
97
1034
0.92
0.28
4.3
3.1
mmol/l
5.9
7.1
2.46
89
842
(3022145) Colonoscopy Study observation
44
395
1.13
0.28
1.6
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
64
1.25
0.27
1.4
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
302
2956
1.08
0.27
30.8
14.7
ml/min/173m2
78.6
75.0
2.38
278
2423
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
171
0.81
0.26
1.5
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
73
0.68
0.26
1.6
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
75
1.20
0.25
1.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
76
1.19
0.25
1.6
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
49
447
1.11
0.24
4.3
4.7
%
36.7
32.1
1.98
38
276
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
171
1.18
0.23
1.4
1.4
—
33.7
—
0
13
(3013139) Helicobacter pylori Ag [Presence] in Stool
22
190
1.17
0.23
1.9
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.6
1.4
nmol/l
—
—
—
0
0
(4211845)
0
11
0.00
0.21
0.0
5.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.1
—
349.3
—
0
7
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
292
0.88
0.20
1.7
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
14
0.00
0.20
0.0
1.2
—
7.8
—
0
14
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
296
2909
1.06
0.20
5.4
4.8
mu/l
1.9
2.4
0.67
271
2588
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
186
0.85
0.19
1.2
1.2
iu/ml
75.4
144.2
—
8
66
(3019230) Fractional oxyhemoglobin in Venous blood
6
51
1.18
0.19
46.0
1.8
%
78.2
59.5
—
6
51
(3035350) Ketones [Presence] in Urine by Test strip
164
1587
1.06
0.19
5.4
4.2
estimate
0.0
0.0
0.00
50
310
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
58
1.21
0.18
1.6
1.6
iu/l
28.8
20.0
—
7
49
(40768800) Prostate Pathology biopsy report
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
69
1.16
0.16
1.4
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
87
0.80
0.14
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
84
876
0.95
0.14
6.3
3.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
164
1605
1.04
0.11
7.3
5.7
estimate
0.0
0.0
0.00
52
302
(40761535) Cells panel - Urine sediment
30
280
1.08
0.10
3.4
3.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
238
0.92
0.10
4.3
3.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
45
1.11
0.10
1.4
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
165
1619
1.03
0.09
5.5
4.2
estimate
0.0
0.0
0.00
50
294
(3021788) Differential panel - Synovial fluid
5
47
1.06
0.09
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
58
1.03
0.08
1.2
1.2
u/l
21.8
18.0
—
6
48
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
61
0.82
0.08
1.2
1.2
nmol/l
1.2
0.8
—
5
49
(3014051) Protein [Presence] in Urine by Test strip
7
81
0.86
0.07
4.0
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
163
0.92
0.07
1.7
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
154
1516
1.03
0.07
4.5
4.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
131
1.07
0.03
2.8
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
152
1.05
0.02
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
80
790
1.02
0.02
1.4
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
227
2260
1.01
0.02
7.7
4.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
273
2722
1.01
0.01
33.9
16.4
%
38.4
39.2
0.69
167
1780
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
148
1.01
0.00
2.0
1.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
16
162
0.99
0.00
5.8
2.9
u/ml
40.1
57.7
0.31
16
157
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
161
0.99
0.00
1.9
2.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
134
0.97
0.00
2.1
2.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
49
1.02
0.00
1.6
1.3
nmol/l
0.5
0.6
—
5
44
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.4
—
8.7
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
58
0.86
0.00
1.2
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
55.8
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
7
70
1.00
0.00
3.1
2.9
umol/l
30.4
31.1
—
7
56
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
1.2
—
0
8
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
52
0.96
0.00
1.4
1.7
pmol/l
174.2
246.2
—
5
46
(3006462) Nitrate [Presence] in Urine
0
9
0.00
0.00
0.0
6.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
16.3
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
9
90
1.00
0.00
7.3
8.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint MYCOBLUNGATYPICA and mortality.

Females

Parameter HR [95% CI] p-value
MYCOBLUNGATYPICA 1.744 [1.51, 2.02] < 0.001
Birth year 0.995 [0.99, 1.0] 0.209

During the follow-up period (1.1.1998 — 31.12.2019), 571 out of 1246 females with MYCOBLUNGATYPICA died.

Males

Parameter HR [95% CI] p-value
MYCOBLUNGATYPICA 3.148 [2.47, 4.01] < 0.001
Birth year 0.986 [0.98, 1.0] 0.011

During the follow-up period (1.1.1998 — 31.12.2019), 490 out of 842 males with MYCOBLUNGATYPICA died.

Mortality risk

Mortality risk for people of age

years, who have MYCOBLUNGATYPICA.

N-year risk Females Males
1 0.123% 0.602%
5 0.936% 3.554%
10 2.477% 8.216%
15 5.023% 15.414%
20 8.501% 25.509%

Relationships between endpoints

↥

Index endpoint: MYCOBLUNGATYPICA – Atypical mycobacterium lung infection

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data